Debate Erupts after Mercury Found in Chinese Medicine
(Beijing) – One of the largest producers and retailers of Chinese medicine has said its products comply with national standards and are safe if patients follow prescriptions, but this has not quieted an online debate.
Beijing Tong Ren Tang Group Co. Ltd. made the announcement on May 22 weeks after a batch of its Chinese medicine was recalled on May 7 by Hong Kong's Department of Health because excessive levels of mercury were found.
- Stock Market Supervisor Slowly Fills Job Slots
- Record Number of Applicants in China Vie for 'Iron Rice Bowl' Jobs
- Chinese State-Owned Shipping Company Declared Bankrupt
- China's SOE Supervisor Gets Tough on Corruption
- Li Ka-shing Company to Tune Out Satellite TV Channel
- China to Conduct Second National Pollution Survey
- Li Ka-shing Sells Shanghai Commercial Complex for 20 Billion Yuan
- China's Industrial Profit Growth Slows; Ferrous Metal Sector Surges
- New Regulations Target Bad Loans of 'Zombie Enterprises'
- Closer Look: Future Looks Brighter for Insurance Companies' Third-Party Asset Managers
- Sign up to receive our free daily newsletter
- Chinese Workers' Salaries Fail to Keep Pace with GDP Growth, Study Finds
- Shanghai Seeks to Enforce Ban on Overseas Curricula at International Schools
- Air China Jet Flies in Wrong Direction after Takeoff
- Air-Scrubbing Tower Gives Beijingers Breathing Room
- China's Largest Cities Attracting Fewer Migrants, Study Shows
- Holiday-Season Ticket Sales See First Decline In Nearly Decade
- Gap Between Outbound Direct Investment, Foreign Direct Investment Continues to Grow
- Xiaomi Unveils New Smartphones as Apple and Samsung Falter
- Poor Parenting Hinders Development of China's Rural Children, Study Shows
- Debt-To-Equity Can't Be The Only Way to Deal With Corporate Debt